Skip to main content
Top
Published in: Annals of Hematology 1/2010

01-01-2010 | Original Article

Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection

Authors: Olga Katsarou, Evangelos Terpos, Pantelis Chatzismalis, Stefanos Provelengios, Theophanis Adraktas, Dimitrios Hadjidakis, Anna Kouramba, Anastasia Karafoulidou

Published in: Annals of Hematology | Issue 1/2010

Login to get access

Abstract

Osteoporosis has been recently recognized as a severe comorbidity factor in hemophilia. However, its pathogenesis is still obscure. We evaluated the incidence of osteoporosis in 90 hemophilia patients and investigated possible correlations with clinical and laboratory data. Out of the 90 patients, 80 (89%) had severe hemophilia, and 35 (38.9%) were human immunodeficiency virus (HIV)-positive. Hemophilic arthropahty was assessed using World Federation of Hemophilia clinical score and Petterson radiological score. Bone mineral density of the lumbar spine (LS) and femoral neck (FN) were measured using dual-energy X-ray absortiometry. Bone turnover was evaluated by the measurement of: (1) bone resorption markers [N-terminal cross-linking telopeptide of collagen type I (NTX), C-terminal cross-linking telopeptide of collagen type I (CTX), and tartrate-resistant acid phosphatase isoform-5b (TRACP-5b)], (2) bone formation markers [bone-alkaline phosphatase (bALP) and osteocalcin], and (3) osteoclast stimulators (receptor activator of nuclear factor-κB ligand, osteoprotegerin, and tumor necrosis factor-alpha). Osteopenia or osteoporosis was observed in 86% and 65% of the patients in FN and LS, respectively. Osteoporosis was more common among HIV-positive patients in both FN (65.3% vs 41.6%; p = 0.007) and LS (17.86% vs 5.41%, p = 0.004). The severity of osteoporosis in FN correlated with the patients' total clinical and radiological score (p = 0.001). Hemophilia patients showed increased osteoclastic activity (significant increase of TRACP-5b, NTX, and CTX), which was not accompanied by a comparable increased bone formation (reduced osteocalcin and borderline increase of bALP). In multivariate analysis, HIV infection (p = 0.05) and total clinical score (p = 0.001) were independent risk factors for osteoporosis development. We conclude that there is a high prevalence of osteoporosis among hemophiliacs, which is related to the severity of arthropathy and is enhanced by HIV infection. We report for the first time a high bone resorption that seems not to be balanced by a comparable bone formation.
Literature
1.
go back to reference Genant HK, Cooper C, Poor G et al (1999) Interim report and recommendation of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259–264CrossRefPubMed Genant HK, Cooper C, Poor G et al (1999) Interim report and recommendation of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259–264CrossRefPubMed
2.
go back to reference National Institutes of Health (2000) NIH consensus statement osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 17:1–45 National Institutes of Health (2000) NIH consensus statement osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 17:1–45
8.
go back to reference Gallacher SJ, Deighan C, Wallace AM et al (1994) Association of severe hemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 87:181–186PubMed Gallacher SJ, Deighan C, Wallace AM et al (1994) Association of severe hemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med 87:181–186PubMed
12.
go back to reference Pettersson H (1994) Can join damage be quantified? Semin Hematol 31(Suppl 2):1–4 Pettersson H (1994) Can join damage be quantified? Semin Hematol 31(Suppl 2):1–4
14.
go back to reference Binkley NC, Schmeer P, Wasnich RD et al (2002) What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 5(Suppl):19–27. doi:10.1385/JCD:5:3S:S19 CrossRef Binkley NC, Schmeer P, Wasnich RD et al (2002) What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 5(Suppl):19–27. doi:10.​1385/​JCD:​5:​3S:​S19 CrossRef
16.
18.
go back to reference Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N et al (2008) Inactivity is a risk factor for bone mineral density among haemophilic children. BJH 140:562–567CrossRef Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N et al (2008) Inactivity is a risk factor for bone mineral density among haemophilic children. BJH 140:562–567CrossRef
24.
go back to reference Schiefke I, Fach A, Wiedmann M et al (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed Schiefke I, Fach A, Wiedmann M et al (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847PubMed
26.
go back to reference Landonio S, Quirino T, Bonfanti P et al (2004) Osteopenia and osteoporosis in HIV + patients, untreated or receiving HAART. Biomed Pharmacother 58:505–508PubMed Landonio S, Quirino T, Bonfanti P et al (2004) Osteopenia and osteoporosis in HIV + patients, untreated or receiving HAART. Biomed Pharmacother 58:505–508PubMed
27.
go back to reference Mondy K, Yarasheski K, Powderly WG et al (2003) Longitudinal evolution of bone mineral density and bone markers in HIV-infected individuals. Clin Infect Dis 36:482–490. doi:10.1086/367569 CrossRefPubMed Mondy K, Yarasheski K, Powderly WG et al (2003) Longitudinal evolution of bone mineral density and bone markers in HIV-infected individuals. Clin Infect Dis 36:482–490. doi:10.​1086/​367569 CrossRefPubMed
33.
go back to reference Brown TT, Ruppe MD, Kassner R et al (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab 89:1200–1206. doi:10.1210/jc.2003-031506 CrossRefPubMed Brown TT, Ruppe MD, Kassner R et al (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab 89:1200–1206. doi:10.​1210/​jc.​2003-031506 CrossRefPubMed
35.
go back to reference Katzman DK, Bachrach LK, Carter DR, Marcus R (1991) Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73:1332–1339CrossRefPubMed Katzman DK, Bachrach LK, Carter DR, Marcus R (1991) Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73:1332–1339CrossRefPubMed
Metadata
Title
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection
Authors
Olga Katsarou
Evangelos Terpos
Pantelis Chatzismalis
Stefanos Provelengios
Theophanis Adraktas
Dimitrios Hadjidakis
Anna Kouramba
Anastasia Karafoulidou
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0759-x

Other articles of this Issue 1/2010

Annals of Hematology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.